|
Volumn 16, Issue 6 Suppl 6, 2002, Pages 97-105
|
Docetaxel and radiation as combined-modality therapy.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
DRUG DERIVATIVE;
PACLITAXEL;
RADIOSENSITIZING AGENT;
TAXOID;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
COMBINED MODALITY THERAPY;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
RADIATION-SENSITIZING AGENTS;
TAXOIDS;
|
EID: 0036616648
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (30)
|
References (56)
|